Circulating tumor necrosis factor alpha may modulate the short-term detraining induced muscle mass loss following prolonged resistance training by McMahon, G et al.
McMahon, G and Morse, CI and Winwood, K and Burden, A and Onambélé,
GL (2019)Circulating tumor necrosis factor alpha may modulate the short-
term detraining induced muscle mass loss following prolonged resistance
training. Frontiers in Physiology, 10. ISSN 1664-042X
Downloaded from: http://e-space.mmu.ac.uk/623188/
Version: Published Version
Publisher: Frontiers Media
DOI: https://doi.org/10.3389/fphys.2019.00527
Usage rights: Creative Commons: Attribution 4.0
Please cite the published version
https://e-space.mmu.ac.uk
fphys-10-00527 April 30, 2019 Time: 16:53 # 1
ORIGINAL RESEARCH
published: 03 May 2019
doi: 10.3389/fphys.2019.00527
Edited by:
Sebastian Bohm,
Humboldt University of Berlin,
Germany
Reviewed by:
Kohei Watanabe,
Chukyo University, Japan
Gaspar Epro,
London South Bank University,
United Kingdom
*Correspondence:
Gerard McMahon
g.mcmahon@ulster.ac.uk
Specialty section:
This article was submitted to
Exercise Physiology,
a section of the journal
Frontiers in Physiology
Received: 06 February 2019
Accepted: 12 April 2019
Published: 03 May 2019
Citation:
McMahon G, Morse CI,
Winwood K, Burden A and
Onambélé GL (2019) Circulating
Tumor Necrosis Factor Alpha May
Modulate the Short-Term Detraining
Induced Muscle Mass Loss Following
Prolonged Resistance Training.
Front. Physiol. 10:527.
doi: 10.3389/fphys.2019.00527
Circulating Tumor Necrosis Factor
Alpha May Modulate the Short-Term
Detraining Induced Muscle Mass
Loss Following Prolonged
Resistance Training
Gerard McMahon1,2* , Christopher I. Morse2, Keith Winwood2, Adrian Burden2 and
Gladys L. Onambélé2
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Introduction: Tumor necrosis factor alpha (TNFα) is a pro-inflammatory cytokine that
has been shown to modulate muscle mass, and is responsive to exercise training. The
effects of resistance training (RT) followed by a short period of detraining on muscle
size, architecture and function in combination with circulating TNFα levels have not been
previously investigated in a young, healthy population.
Methods: Sixteen participants (8 males and 8 females) were randomly assigned to a
training group (TRA; age 20 ± 3 years, mass 76 ± 7 kg), whilst fourteen participants (7
males and 7 females) age 22 ± 2 years, mass 77 ± 6 kg were assigned to a control
group (CON). Measures of vastus lateralis (VL) muscle size (normalized physiological
cross-sectional area allometrically scaled to body mass; npCSA), architecture (fascicle
length; LF, pennation angle Pθ), strength (knee extensor maximal voluntary contraction;
KE MVC), specific force, subcutaneous fat (SF) and circulating TNFα were assessed at
baseline (BL), post 8 weeks RT (PT), and at two (DT1) and four (DT2) weeks of detraining.
Results: Pooled BL TNFα was 0.87 ± 0.28 pg/mL with no differences between groups.
BL TNFα tended to be correlated with npCSA (p = 0.055) and KEMVC (p = 0.085)
but not specific force (p = 0.671) or SF (p = 0.995). There were significant (p < 0.05)
increases in npCSA compared to BL and CON in TRA at PT, DT1, and DT2, despite
significant (p < 0.05) decreases in npCSA compared to PT at DT1 and DT2. There were
significant (p < 0.05) increases in LF, Pθ and KE MVC at PT but only LF and torque at
DT1. There were no significant (p > 0.05) changes in SF, specific force or TNFα at any
time points. There was a significant correlation (p = 0.022, r = 0.57) between the relative
changes in TNFα and npCSA at DT2 compared to PT.
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Discussion: Neither RT nor a period of short term detraining altered the quality of
muscle (i.e., specific force) despite changes in morphology and function. TNFα does
not appear to have any impact on RT-induced gains in muscle size or function,
however, TNFα may play a role in inflammatory-status mediated muscle mass loss
during subsequent detraining in healthy adults.
Keywords: cytokine, inflammation, muscle architecture, specific force, young
INTRODUCTION
Reduced levels of skeletal muscle mass and strength are associated
with many chronic diseases and increased mortality in humans
(Rantanen, 2003; Oterdoom et al., 2009; Kalyani et al., 2014;
Bowen et al., 2015), understanding the fundamental adaptation
of skeletal muscle is therefore, key to optimizing health and
longevity. Skeletal muscle displays remarkable plasticity with its
ability to alter its phenotype in response to mechanical/metabolic
stimuli or lack thereof, with an increase (hypertrophy) or
decrease (atrophy) in muscle fiber size, respectively (Coffey and
Hawley, 2007; Wackerhage et al., 2018). Resistance exercise is
well established as a potent stimulus for acutely altering muscle
protein synthetic rates (MacDougall et al., 1995), and following
repeated resistance training (RT) sessions over a period of time,
this stimulus ultimately results in an increase in skeletal muscle
mass and strength [e.g., (Moritani and DeVries, 1979; Young
et al., 1983; Frontera et al., 1988; McMahon et al., 2012, 2014,
2018)]. During a period of detraining (DT) however, preceding
gains in muscle fiber size are rapidly diminished. For example,
in a mouse model, Jespersen et al. (2011), demonstrated that
following 90 days of RT, almost 50% of the RT-induced increase
in muscle fiber size was lost after only 10 days of DT. In humans,
detraining in the form of 5–6 weeks immobilization, following
5–6 months of RT, resulted in a 41% loss of RT-induced gains
in elbow flexor strength, and 33 and 25% reduction in fast/slow
twitch muscle fiber size, respectively, in healthy male subjects
(MacDougall et al., 1980). Early work from Häkkinen and
Komi (1983) demonstrated that following 16 weeks of strength
training in young, healthy males, muscle strength and integrated
electromyography (iEMG) of the leg extensors were significantly
increased. Following a subsequent 8 week detraining period, the
significant reductions in muscle force were accounted for by a
reversal of the preceding RT induced gains in neuromuscular
variables. More recently, Blazevich et al. (2007) reported that
following 10 weeks of either concentric or eccentric RT in young
men and women, there were significant improvements in muscle
volume, physiological cross-sectional area (pCSA), architecture
and training mode specific strength. Following 3 months of
detraining, there was a significant, contraction mode specific,
decrement in strength (eccentric only) and interestingly non-
significant changes in hypertrophic and architectural measures.
Despite this evidence in RT and subsequent DT studies of longer
durations, which may reflect different patterns of adaptation to
RT and DT, periods of DT following RT and the associated
alterations to muscle mass and function to date have been
poorly characterized in young, healthy adults following short-
term detraining such as 1–4 weeks’ post-RT. To the authors’
knowledge, there are only a few studies that have been published
previously that have reported changes to muscle mass and
strength following short-term DT (≤4 weeks) following a RT
only program (i.e., not part of a concurrent RT and endurance
training program) (Kubo et al., 2010; McMahon et al., 2012;
Yasuda et al., 2015). However, large methodological discrepancies
make these studies incomparable due to factors such as muscle
groups analyzed, length of the preceding training period,
measurement points during detraining, and differences in muscle
size and strength measurements. Our paper has previously
demonstrated that muscle size (anatomical cross-sectional area
[aCSA]) and maximal voluntary contraction (MVC) torque is
significantly elevated above baseline following 8 weeks of RT
and remained elevated following a further 2 and 4 weeks of
detraining (McMahon et al., 2012), although these varied slightly
depending on the training group. Two factors that are critical
in fully describing muscles’ characteristics are physiological
cross-sectional area (the area of muscle at right angles to the
longitudinal axis of the fibers) and the muscle’s specific force
(normalization of force per unit pCSA) which, in combination
with neural factors (Moritani and DeVries, 1979; Del Vecchio
et al., 2019) provide a true representation of the muscle size and
intrinsic force generating capacity. Neither pCSA nor specific
force have been investigated in short-term (≤4 weeks) detraining
studies, with specific force, to the author’s knowledge, not within
any length of detraining studies following a period of RT.
In addition to RT acting as stimuli for phenotype changes,
the endocrine system also plays a critical role in phenotype
expression by having the ability to tip the balance of muscle
cellular anabolism and catabolism through influence of various
growth factors and cytokines (Solomon and Bouloux, 2006). One
such cytokine (or myokine when secreted from muscle) that
plays an integral role in altering muscle state is tumor necrosis
factor alpha (TNFα). TNFα is a pro-inflammatory cytokine that is
associated with the modulation of muscle tissue loss, particularly
in pathological disease such as cancer cachexia (Balkwill, 2006)
and Sarcopenia (Visser et al., 2002). For example, high levels
of circulating IL-6 and TNFα have been associated with lower
muscle mass and strength in well-functioning older adults (Visser
et al., 2002). Loss of specific muscle proteins such as myosin heavy
chain (MHC) content are modulated by TNFα- mediated effects
on the p38 MAPK and nuclear factor-κB (NF-κB) pathways of
the ubiquitin-proteasome pathway (Li et al., 1998, 2005; Li and
Reid, 2000). Li et al. (1998) demonstrated that following 72 h of
1–6 ng/mL of TNFα treatment on differentiated mouse skeletal
muscle C2C12 myotubes, there were significant protein content
losses. Furthermore, concentrations as low as 1–3 ng/mL induced
losses of adult MHC protein in a concentration dependent
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manner in primary cultures from rat skeletal muscle. These losses
were not associated with a decrease in muscle DNA content
or a decrease in MHC protein synthesis, which is reflective of
chronic muscle wasting (Li et al., 1998). In a subsequent study
from the same group (Li et al., 2005) also demonstrated that
following intraperitoneal injection of 6 ng/mL of TNFα, Atrogin-
1/MAFBx expression increased by 76.2 ± 17.1% after 4 h and
87.7 ± 10.1% after 6 h in adult gastrocnemius muscles of mice.
Previous research into the impact of RT on TNFα levels has been
mainly conducted in only elderly or diseased populations, with
only sparse data in a young population currently available. Other
methodological issues within the literature is that many studies
have investigated concurrent training (i.e., combinations of RT
and endurance training), not singularly RT and provide little or
no insight into changes in muscle mass or function. Louis et al.
(2007) reported that following an acute bout of RT in young
adults, TNFα mRNA was significantly increased immediately
and for up to 24-h post-RT. In a study by Townsend et al.
(2013) also investigating the acute response to RT, the authors
showed that in resistance-trained men, circulating TNFα was
significantly increased immediately post-RT compared to pre-RT.
However, TNFα levels had returned to baseline within 30 min
post-RT, remaining as such for a further 24 and 48 h. This is
in somewhat of agreement with the study of Alves et al. (2013)
who demonstrated that following either eccentric or concentric
RT only, there were no acute increases in TNFα post-RT (24–
96 h). Furthermore, this study also showed that following 10
RT sessions over 3 weeks, there were no significant changes
in circulating TNFα 24–96 h post the final RT session. Paoli
et al. (2015) report that following 8 weeks of upper body RT in
combination with either a high-or-low protein diet, despite no
significant alterations in the acute circulating TNFα response,
the authors noted chronic RT could elevate both the basal and
RT-induced response of circulating TNFα. The authors of this
previous study, however, report neither changes in muscle mass
or strength. Furthermore, data from Bruunsgaard et al. (2004)
demonstrate that muscle strength after 12 weeks of RT in 86–
95 year olds is inversely correlated with TNFα receptor content,
showing that the TNFα system can also impact on muscle
function. Currently there are no investigations on TNFα levels
and concomitant changes in muscle size and strength in younger
adults following a sustained RT program only, and following a
period of short-term detraining.
Therefore, the aims of this study were to (1) investigate
the effects of RT and DT on muscle size and function, (2)
describe changes in TNFα levels following RT and DT, and (3)
probe whether there is any link between changes in muscle
size and function and circulating TNFα levels in a young,
healthy population.
MATERIALS AND METHODS
Participants
Thirty young participants recruited from the local university
campus, gave written informed consent to participate in the
study in accordance with the Declaration of Helsinki. All
procedures and experimental protocols were approved by
the Manchester Metropolitan University Cheshire Campus
ethics committee. Exclusion criteria included the presence
of any known musculoskeletal, neurological, inflammatory,
or metabolic disorders or injury. Participants took part in
recreational activities such as team sports and had either
never taken part in lower limb RT or had not done so
within the previous 12 months. Each participant completed
a physical activity diary, outlining that they each habitually
completed 3–5 h of non-resistance based moderate physical
activity per week. Sixteen participants were randomly assigned
to a training group (TRA) age 20 ± 3 years, mass 76 ± 7 kg),
whilst fourteen participants (7 males and 7 females) age
22 ± 2 years, mass 77 ± 6 kg were assigned to a
control group (CON).
Study Design
The study design was convenience sampling, with participants
separated into groups by random allocation to one of two
groups (i.e., training or control). Following familiarization
with laboratory procedures at least 1 week prior to testing
proper, participants were assessed for muscle morphology,
architectural and functional properties and TNFα at baseline
(week 0). Measurements were repeated after 8 weeks of
RT (post-training [PT]), week 10 following 2 weeks of
detraining (DT1) and week 12 following a further 2 weeks
detraining (DT2).
Resistance Training
Resistance training was performed three times per week
for 8 weeks at 80% of 1 repetition maximum (1RM) on
the knee extensor complex. Exercises included the back
squat, leg press, leg extension (Technogym, Berkshire,
United Kingdom), lunge, Bulgarian split squat and Sampson
chair. All exercise sessions were supervised by a member of
the research team. Participants completed two familiarization
sessions at 70%1RM prior to commencing the RT program.
1RMs were measured at baseline and every 2 weeks, with
loading weight progressed. Each training session consisted
of four exercises with participants performing three sets of
10 repetitions per exercise for the first 4 weeks, and four
sets of eight repetitions per exercise thereafter. Training
records were diligently completed during sessions. Following
RT, participants returned to habitual daily activities with
no form of exercise training permitted for the detraining
period (4 weeks).
Assessment of Muscle Morphology
All muscle morphological and architectural measures were taken
at rest with each participant seated in an upright position on
an isokinetic dynamometer (Cybex, CSMi, MA, United States).
After calibration, each participant was positioned with a hip
angle of 80◦ (straight back 90◦) and knee at 90◦ knee flexion
(straight leg 0◦). All measurements were determined using
ultrasonography (AU5, Esaote Biomedica, Genoa, Italy) at rest
with a 40 mm probe, with images captured at 25 Hz using
a digital video recorder (Tevion, Medion Australia Pty Ltd.,
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St Leonards, Australia). The measurement sites were 25, 50,
and 75% of femur length. Femur length was defined as the
line passing from the greater trochanter to the central palpable
point of the space between the femur and tibia heads when
the knee was flexed at 90◦. Vastus lateralis fascicle pennation
angle (θ) was measured as the angle of fascicle insertion into
the deep aponeurosis. Images were obtained perpendicular
to the dermal surface of the VL and oriented along the
midsagittal plane of the muscle. The transducer was then
aligned in the fascicle plane to capture an optimal number
of clearly demarked fascicles. Images were taken at 25, 50,
and 75% of the total femur length (as described below) and
50% of muscle width at each point (where 50% muscle width
is defined as the midpoint between the fascia separating the
VL and rectus femoris, and fascia separating the VL and
biceps femoris muscles). Fascicle length was defined as the
length of the fascicular path between the deep aponeurosis and
superficial aponeurosis of the VL. The majority of fascicles
extended off the acquired image, where the missing portion
was estimated by linear extrapolation. This was achieved by
measuring the linear distance from the identifiable end of a
fascicle to the intersection of a line drawn from the fascicle
and a line drawn from the superficial aponeurosis. This method
has been shown to produce reliable results previously (Blazevich
et al., 2007). All images were analyzed and measured using
Image J v.1.43c (National Institutes of Health, Bethesda, MD,
United States). Subcutaneous fat was estimated using the same
images as taken for muscle architecture and analyzed at 50%
femur length only. After calibration in Image J to coincide
with the scale of the ultrasound image, a line from the top
to the bottom of the layer of fat visualized was drawn at
three regular intervals on the ultrasound image. The average
lengths of these three lines were taken to estimate the average
thickness of the subcutaneous fat layer in millimeters. Care
was taken not to deform or compress the subcutaneous fat
with minimal pressure applied to the dermal surface with the
ultrasound probe.
For a full description of aCSA methods please see Reeves
et al. (2004a) The aCSA was measured with the probe
aligned in the axial plane. Echo-absorptive tape was placed
at regular intervals (∼3 cm) along the muscle width at each
site so that when the probe was placed on the leg, two
distinct shadows were cast on the ultrasound image. Therefore,
each ultrasound image provided a section of VL within the
boundaries set by the two shadows and fascia surrounding
the muscle. Each of these sections was analyzed for the
total area using Image J to provide a total aCSA at that
particular site.
The measurement techniques used for the calculation of
physiological cross-sectional area of the vastus lateralis (VL)
muscle in the current study has been previously documented
elsewhere (Reeves et al., 2004a; McMahon et al., 2014). Using
the aCSA measures, muscle volume was then calculated using
the truncated cone method, which has been validated in a
number of previous studies (Esformes et al., 2002; Reeves
et al., 2004b). VL pCSA was calculated by dividing muscle
volume by fascicle length (Reeves et al., 2004b). Allometric
scaling was then used to normalize (npCSA) to body mass
(Jaric et al., 2005).
Knee Extensor Maximal Voluntary
Contraction (KE MVC) and Vastus
Lateralis Specific Force
Prior to this assessment, a number of measures were taken
to minimize inaccuracies during the dynamometer assessments,
thereby counteracting any potential effect of soft tissue
compliance, dynamometer alignment, as well as gravitational
forces. With these precautions in place, maximal isometric knee
extension torque was measured with the knee at 70◦ knee flexion
(full knee extension = 0◦) on the right leg of all participants,
corresponding to the angle of peak torque. After a series of
warm up trials consisting of ten isokinetic contractions at
60◦.s−1 at self-perceived 50–85% maximal effort, participants
were instructed to rapidly exert maximal knee extensor isometric
force (maximal voluntary contraction, KE MVC) against the
dynamometer lever arm. Joint torque data traces were displayed
on the screen of a MacBook Air computer (Apple Computer,
Cupertino, CA, United States), which was interfaced with an
A/D system (Acknowledge, Biopac Systems, Santa Barbara, CA,
United States) with a sampling frequency of 2000 Hz. Isometric
contractions were held for ∼2–3 s at the plateau with a 60 s rest
period between contractions. Peak torque was expressed as the
average of data points over a 500 ms period at the plateau phase
(i.e., 250 ms either side of the instantaneous peak torque). The
peak torque of three extensions was used as the measure of torque
in each participant.
A pair of Ag-AgCl electrodes (Neuroline 720, Ambu,
Denmark), were placed on clean, shaved, and abraded skin,
at 50% of femur length, in the mid-sagittal plane of the
biceps femoris. The reference electrode (Blue sensor L, Ambu,
Denmark) was placed on the lateral tibial condyle. The raw
EMG signal was preamplified (MP100, Biopac Systems Inc.,
United States), amplified × 1000 (MP100, Biopac Systems Inc.,
United States), bandpass filtered between 10 and 500 Hz (Biopac
Systems, United States) with a notch at 50 Hz, and sampled at
2000 Hz. All EMG and torque signals were displayed in real time
in AcqKnowledge software (Biopac systems Inc., United States)
via a PC. Two maximal knee flexion contractions were carried
out to obtain the EMG at maximal flexion torque. The root
mean square (RMS) EMG activity was averaged for a 500 ms
period (average of 1.5 ms moving windows) which coincided
with the plateau of peak KE MVC torque. To reiterate, the EMG
of the long head of the biceps femoris muscle was measured to
ascertain the level of antagonist muscle co-contraction during
knee extensor MVC. The biceps femoris torque during a knee-
flexion contraction was calculated as described by McMahon et al.
(McMahon et al., 2014) whereby a linear relationship between
BF EMG and KE MVC torque is assumed, thus enabling the
quantification of the “pull back torque” during knee extensions,
and ultimately, the total forces experienced by the patella tendon
(Pearson and Onambele, 2005, 2006).
Muscle specific force was calculated in multiple steps as
previously reported (Reeves et al., 2004b). Briefly, VL fascicle
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force was calculated by dividing the estimated VL muscle force by
the Cosθ angle of pennation at 50% femur length. Specific force
of the VL muscle was calculated at the knee joint angle where
maximal fascicle force peaked, which corresponded to the knee
joint angle of 70◦ before and after training. Specific force was
calculated by dividing fascicle force by pCSA.
Circulating Tumor Necrosis Factor Alpha
(TNFα) Levels
Pre-, post-training and during detraining, following an overnight
fast, (∼10 h), participants reported to the laboratory between
9 and 11am. 5 mL blood samples were collected from the
antecubital vein of the forearm, placed in a crushed ice bed for
1.5 to 2-h, and then centrifuged at 4◦C for 10 min at 4,800 rpm,
with the supernatant being removed and stored in at least two
aliquots in eppendorf at −20◦ Celsius for later analysis. TNFα
was analyzed using the standard enzyme-linked immuno-sorbent
assay (ELISA) procedure, as described previously (McMahon
et al., 2013). Post-training samples were taken 3–4 days post
final training session, at the same time-of-day as the pre-training
sampling for each participant, with detraining samples being
taken twice fortnightly after the post-training sample date. The
laboratory tests were timed to avoid diurnal variability or acute
exercise-induced cytokine fluctuations. In CON group, TNFα
analysis, n = 6 (3 males, 3 females) with TRG n = 16.
Statistical Analyses
Data were parametric (as determined through Shapiro Wilk and
Levene’s tests) and were therefore analyzed using a mixed-design
repeated measures ANOVA. The within factor was the phase of
training (i.e., weeks 0, 8, 10, and 12) and the between factor was
group (TRG or CON). All data are presented as mean ± SD.
Statistical significance was set with alpha at p ≤ 0.05. In terms of
the sample size in this study, the average statistical power of the
measured muscle parameters (VLCSA, pennation angle, fascicle
length, and KE MVC was statistically adequate at beta = 0.89.
RESULTS
There were no significant differences (p > 0.05) between
TRA and CON groups (independent t-tests) in any of the
measured muscle variables, at baseline. Pooled baseline TNFα
was 0.87± 0.28 pg/mL with no differences between groups. There
was a tendency for baseline TNFα to be correlated with npCSA
(p = 0.055) and also KEMVC (p = 0.085), however, there was no
correlation with specific force (p = 0.671) or SF (p = 0.995).
Muscle Morphology
There were significant absolute increases (p < 0.01) in npCSA
compared to baseline at all time points (PT, DT1, and DT2) in
TRA (Figure 1), with no changes in CON (p > 0.05). There
were also significant relative changes in npCSA at all time points
(26 ± 23%, 18 ± 20%, and 12 ± 19% for PT, DT1, and DT2,
respectively) compared to baseline and controls (p< 0.05). When
compared to PT, there were significant absolute (Figure 1) and
FIGURE 1 | Changes in vastus lateralis normalized physiological
cross-sectional area (npCSA) in TRA group at baseline, post-training (PT),
detraining 1 (DT1), and detraining 2 (DT2). ∗Significantly different to baseline
p < 0.001, †Significantly different to PT p < 0.05.
relative (−6 ± 8% and −10 ± 8%) reductions in npCSA in TRA
at DT1 and DT2, respectively, and versus controls (p< 0.05).
All Pθ data are presented in Table 1. There was a significant
effect of time on absolute changes in Pθ, with the only significant
difference found between Pθ at PT and DT2 in within TRA
changes, with no significant difference between TRA and CON
at any time point. There was a significant (p < 0.05) change in
Pθ at PT compared to baseline and CON but not at DT1 or DT2
in TRA, with no changes (p > 0.05) in CON at any time point.
There were no significant (p > 0.05) differences in Pθ at DT1 or
DT2 compared to PT in TRA.
All LF data are presented in Table 1. There were significant
(p < 0.01) absolute increases in LF at PT and DT1 compared to
baseline and CON, but not at DT2 (p > 0.05) in TRA, with no
changes in CON at any time point. There were also significant
(p < 0.05) absolute decreases in LF at DT1 and DT2 compared
to PT. There were significant (p < 0.01) relative increases in LF
at PT and DT1 compared to baseline and CON, but not at DT2
(p > 0.05) in TRA, with no relative changes in CON at any time
point. There were also significant (p < 0.05) relative decreases in
LF at DT1 and DT2 compared to PT.
There were no significant absolute or relative changes in SF
compared to baseline at any time points (PT, DT1, and DT2) in
TRA or CON (p > 0.05, Table 1). There were no correlations
between subcutaneous fat levels and TNFα levels at any point.
Knee Extensor Maximal Voluntary
Contraction (KE MVC) and Vastus
Lateralis Specific Force
All torque data are presented in Table 1. There were significant
absolute and relative increases (p < 0.05) in KE MVC at PT and
DT1 compared to baseline in TRA with no changes in CON.
There were no significant absolute decreases in KE MVC at DT1
(p > 0.05) although there were significant absolute decreases in
KE MVC at DT2 (p < 0.01) compared to PT in TRA with no
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TABLE 1 | Functional and architectural properties.
Variable Absolute Relative
BL PT DT1 DT2 PT vs. BL % DT1 vs. BL % DT2 vs. BL % DT1 vs. PT % DT2 vs. PT %
Specific force (N/cm2)
TRA 20.9 ± 5.4 20.7 ± 4.4 20.7 ± 4.5 21.0 ± 4.7 2 ± 20 2 ± 19 3 ± 22 −1 ± 9 −1 ± 6
CON 22.3 ± 7.4 22.8 ± 7.6 23.0 ± 7.1 22.8 ± 7.8 2 ± 6 1 ± 5 2 ± 5 0 ± 3 2 ± 6
KE MVC (N·m)
TRA 248 ± 88 275 ± 94∗ 266 ± 92∗ 259 ± 91† 13 ± 18∗ 9 ± 19∗ 6 ± 17 −4 ± 5 −6 ± 5†
CON 267 ± 76 259 ± 82 262 ± 71 268 ± 84 −1 ± 11 −1 ± 9 0 ± 14 2 ± 8 3 ± 13
VL fascicle force (N)
TRA 1068 ± 365 1266 ± 347 1163 ± 339 1159 ± 313 − − − − −
CON 1723 ± 402 1698 ± 388 1768 ± 342 1788 ± 422
VL pennation angle (◦)
TRA 16.0 ± 1.4 16.5 ± 1.3 16.2 ± 1.1 15.6 ± 1.4 4 ± 6∗ 2 ± 8 −2 ± 8 −2 ± 4 −5 ± 4
CON 14.1 ± 6.3 14.0 ± 6.2 13.9 ± 6.2 14.0 ± 6.1 0 ± 4 −1 ± 5 0 ± 4 −1 ± 2 0 ± 1
VL fascicle length (mm)
TRA 101 ± 16 116 ± 16∗ 112 ± 14∗† 106 ± 13† 16 ± 9∗ 11 ± 9∗ 6 ± 8 −4 ± 3† −9 ± 5†
CON 108 ± 16 111 ± 15 112 ± 16 111 ± 17 3 ± 6 6 ± 6 3 ± 7 2 ± 3 −1 ± 3
Sub fat (mm)
TRA 7.7 ± 6.2 6.9 ± 5.3 7.3 ± 5.8 7.7 ± 6.0 −9 ± 14 −1 ± 18 6 ± 26 10 ± 26 19 ± 40
CON 6.1 ± 4.7 6.4 ± 5.3 6.5 ± 5.3 6.4 ± 5.3 3 ± 12 8 ± 18 3 ± 12 5 ± 18 0 ± 1
BL, baseline; PT, post-training; DT1, detraining 1; DT2, detraining 2; TRA, training group; CON, control group; KE MVC, knee extensor maximal voluntary contraction;
Sub fat, subcutaneous fat; VL, vastus lateralis. ∗Significantly different compared to baseline, †Significantly different to post-training.
FIGURE 2 | Changes in specific force in TRA group at baseline, post-training
(PT), detraining 1 (DT1), and detraining 2 (DT2).
changes in CON. There was also a significant relative decrease in
KE MVC at DT2 (p < 0.05) but not DT1 (p > 0.05) compared
to PT in TRA with no changes in CON. All specific force data
are presented in Table 1. There were no significant (p < 0.05)
absolute or relative changes in specific force at any time point in
TRA (Figure 2) or in CON.
Tumor Necrosis Factor Alpha (TNFα)
There were no significant (p > 0.05) absolute or relative changes
in TNFα compared to baseline or CON in TRA at any time
point (Figure 3). There were also no significant absolute or
relative changes in TNFα compared to PT at DT1 or DT2
(p> 0.05). However, there was a significant correlation (p = 0.022,
FIGURE 3 | Changes in TNFα in TRA group at baseline, post-training (PT),
detraining 1 (DT1), and detraining 2 (DT2).
r = 0.57) between the relative changes in TNFα and npCSA at
DT2 compared to PT.
DISCUSSION
The main findings from the current study are that (1)
following 8 weeks of RT there was no effect on systemic TNFα
levels, and as such the training benefits were independent
of this endocrine parameter, (2) changes in TNFα levels
were significantly correlated with losses in muscle mass
following 4 weeks of detraining, and (3) we report for
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the first time that a short period of DT does not appear
to alter the quality (i.e., specific force) of the remaining
skeletal muscle.
Resistance Training and TNFα Levels
The role of physical activity is apparent, when taking into
account its role in systemic inflammation. Indeed physical
activity is believed to play a central role in the delicate
balance between so-called myokines, which are cytokines
produced by contracting skeletal muscles during physical
activity. Examples of these myokines are interleukin (IL)-
6 and TNF-α (Pratesi et al., 2013). Interestingly, IL-6 has
always been considered a pro-inflammatory cytokine, but
it might display anti-inflammatory effects during exercise
(Pratesi et al., 2013). TNF-α on the other hand, can both
stimulate muscle growth (Chen et al., 2007) but also lipid
metabolism through minimizing the accumulation of lipids
in adipocytes (Wang et al., 2013). Hence, reverting to
a less-active lifestyle following training would cause an
imbalance, resulting in a pro-inflammatory status and the
beginning of a vicious cycle including enhancement of muscle
loss, accumulation of intramuscular fat and a decrease in
muscle strength. This is more or less confirmed by previous
studies showing that low physical activity and/or sedentary
behavior is indeed associated with skeletal muscle atrophy
(Degens and Alway, 2006; Bostock et al., 2013). On the
contrary, physical activity can provide a physiological stimulus,
making the skeletal muscle behave as an endocrine organ,
counteracting inflamed aging (Pratesi et al., 2013). It is
also interesting in the current study that pooled baseline
TNFα levels tended to be correlated (p = 0.055, r = 0.41)
with baseline npCSA in the young population. This would
also reflect the evidence showing that TNFα has a dose-
dependent relationship on MHC loss in skeletal muscle (Li
et al., 1998). It is well established that a chronic low-grade
inflammatory profile (CLIP) is associated with TNFα levels
and age-related Sarcopenia in older populations (Beyer et al.,
2012). Our current data suggests that there may be a possible
role of pro-inflammatory cytokine modulation of muscle mass
even in the younger, healthy adult. However, this is purely
speculative at this point.
Previous research using young participants found that the
mRNA of TNFα was significantly increased immediately and
remained elevated up to 24 h post-resistance exercise (Louis
et al., 2007), which is in contrast to the findings of Franchi et al.
(2014) who did not detect changes in TNFα phosphorylation after
concentric or eccentric resistance exercise. However, circulating
TNFα levels appear to display a shorter temporal pattern.
Townsend et al. (2013) showed with the acute response to RT,
circulating TNFα was significantly increased immediately post-
RT compared to pre-RT in resistance trained men. However,
TNFα levels had returned to baseline within 30 min post-RT,
remaining as such for a further 24 and 48 h. Similarly, Alves
et al. (2013) demonstrated that following either eccentric or
concentric RT only, there were no acute increases in TNFα
post-RT (24–96 h). In addition, Peake et al. (2006) reported
following submaximal and maximal lengthening contractions,
no significant changes in circulating TNFα in either acute
windows of 1–3 h or 1–4 days. The results from the current
study show that systemic levels of TNFα are not significantly
altered by an 8-week RT program. This is also in somewhat
of agreement with the study of Alves et al. (2013) whom
reported that following 10 RT sessions over 3 weeks, there were
no significant changes in circulating TNFα 24–96 h post the
final RT session. The current study is slightly in contrast with
that of Paoli et al. (2015). These authors report that following
8 weeks of upper body RT in combination with either a high-
or-low protein diet, chronic RT could elevate both the basal and
RT-induced response of circulating TNFα. The pre-, post-RT
baseline changes in circulating TNFα levels (5.9 ± 0.46 ng/L to
15.79 ± 7.4 ng/L in normal protein diet, and 6.44 ± 0.65 ng/L
to 11.04 ± 2.16 ng/L in high protein diet) were not directly
compared statistically, rather the authors compared differences
in the acute response to RT at baseline and post 8 weeks
RT. Therefore it is still unclear to the exact effects of RT on
chronic circulating TNFα levels. In addition the authors of the
aforementioned study, however, did not report either changes
in muscle mass or strength, which further compounds the lack
of clarity of what effects marginal changes in TNFα levels
may have, if any at all. Using a slightly different approach,
Rall et al. (1996b) used peripheral blood mononuclear cells
(PBMC) subpopulations under various conditions to investigate
the inflammatory response of a young adult population versus
rheumatoid arthritis and healthy elderly populations to 12 weeks
of progressive RT. There were no changes in TNFα production
in PBMC under any condition in the young healthy adults
following RT. It is worth noting that despite this, the changes
in young adults’ strength was significantly increased post-RT
with data shown in a previous study (Rall et al., 1996a). This
is in agreement with the observations of the current study with
participants undergoing significant improvements in strength
with no changes in TNFα. In a study by Ihalainen et al.
(2018), the authors found that systemic TNFα were significantly
reduced following 24 weeks of combined aerobic and RT in
young men. However, due to 3-fold greater duration of training,
lack of particular details around the RT program variables and
the use of males only, make any comparisons between the
current study and that of Ihalainen et al. (2018) very difficult.
Furthermore, the acute response of TNFα to RT exercise and
endurance exercise have been found to be disparate (Louis
et al., 2007). These observations therefore again highlight the
need for concurrent aerobic and RT programs to be treated
independently from RT programs only, and that a combination
of training modes (RT+ aerobic training) may be more beneficial
for modulating pro-inflammatory cytokines. The lack of change
in TNFα levels following a RT only program are consistent
with those found in previous research in a different age-based
population. In that particular study, 11 middle-aged sedentary
men (49 ± 5 years) completed 16 weeks of RT with no
change in TNFα levels (Libardi et al., 2012). However, it is
worth noting the baseline and post-RT TNFα levels were 3-
fold greater than the current study and could be verging on
clinical levels (Milani et al., 1996). In older populations TNFα
levels have been shown to be sensitive to a RT program with
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reductions in TNFα levels reported following the completion
of such programs (Greiwe et al., 2001; Tomeleri et al., 2016)
with baseline TNFα receptor levels inversely correlated with
changes in strength (Bruunsgaard et al., 2004). Reductions in
systemic TNFα following RT in older populations it must be
pointed out are not universally found, with some studies also
showing no alterations to TNFα levels (Onambélé-Pearson et al.,
2010a,b). Therefore in contrast to the above data regarding
sensitivity of TNFα to RT in older populations, it appears that
following a RT program in young, healthy participants, systemic
TNFα is not sensitive to RT-induced changes in muscle size
and/ or function.
Interestingly, our data demonstrates that the relative
decrease in muscle npCSA from post-RT to 4 weeks of
detraining was significantly correlated with the change in
TNFα levels over the same period, which tended to increase.
Acute systemic administration of TNFα has been shown to
increase the expression of ubiquitin mRNAs in soleus muscles
(Llovera et al., 1997) and reduce protein synthesis rates of
myofibrillar and sarcoplasmic proteins in the gastrocnemius
(Lang et al., 2002). However, in vitro work has demonstrated
that superimposition of anabolic stimuli can ablate the effects
of TNFα on muscle protein loss (Guttridge et al., 2000).
Therefore during a period of detraining, where there is a
lack of anabolic stimuli, changes in TNFα levels may mediate
the loss of muscle mass, however, further work is needed
to support this. Previous work on TNFα suggests these
effects are modulated through TNFα’s upstream effects on
the p38 MAPK and nuclear factor-κB (NF- κB) pathways
of the ubiquitin-proteasome pathway (Li et al., 1998, 2005;
Li and Reid, 2000).
Specific Force
Vastus lateralis muscle specific force did not change in the
current study following RT. This is in contrast to the only
other published study that has investigated in vivo muscle
specific force changes following RT in young individuals. Erskine
et al. (2010) demonstrated that following 9 weeks of RT,
VL muscle specific force increased by 20% in 17 untrained
males. The methods and RT used by Erskine et al. (2010)
were very similar to those of the current study, however,
importantly in the current study we did not assess muscle
activation levels using the interpolated twitch technique. Despite
this there is currently no consensus as to whether maximal
muscle activation, whether supramaximally stimulated or not,
is actually increased following a RT program (Folland and
Williams, 2007). This therefore means that the current data
can still be accurately representative of muscle specific force
changes following RT. Additionally, the study of Erskine et al.
(2010) used males only, however, in the current study 50%
of the training group were females. No data is currently
available on whether there are sex differences in muscle specific
force, although we have previously demonstrated that males
and females have similar relative muscle adaptations to a
RT program, and the authors do not think this explains
the differences between these studies. A reason why there
were no observed changes in muscle specific force in the
current study is that both the npCSA (muscle size) and
torque (muscle strength) were both significantly enhanced
following training, but none more so than the other. In other
studies, muscle strength has increased to a larger degree than
muscle size [e.g., Erskine et al. (2010)] however, due to the
heterogeneous responses of individuals to changes in muscle
size and strength, this relationship was not apparent in the
current study. In conjunction with this, it should also be
pointed out there were no correlations between changes in
muscle size and strength following RT and during DT in
the present study.
Changes in npCSA have not been reported previously
following a short-term period of detraining such as that used
in the current study, nor has specific force been reported
during any detraining literature. Many human muscles, including
the quadriceps are pennate muscles, and therefore aCSA
measurements underestimate pCSA (Wickiewicz et al., 1983).
The pCSA represents the area of sarcomeres arranged in parallel
and thus the maximum amount of cross-bridges that can be
formed during a contraction and is the primary determinant
of maximal muscle force. Importantly, we also normalized
the measured pCSA to body mass through allometric scaling
which is an influential factor when comparing individuals
with heterogeneous body composition. There were significant
reductions in npCSA following both two (−6 ± 8%) and
4 weeks (−10 ± 8%) of DT compared to PT (mean −2.5%
per week). This short term reduction in muscle mass is
consistent with previous observations that used anatomical
CSA measurements (McMahon et al., 2012; Yasuda et al.,
2015). However, as both of these previous studies investigated
the effects of two different training regimens on muscle size,
effects of training and detraining were not the same between
these groups. Despite the aforementioned loss of muscle mass,
npCSA of the VL muscle was still significantly increased
relative to baseline after 4 weeks of detraining. Again this
is in agreement with the data of Yasuda et al. (2015) that
showed following 6 weeks of RT and a subsequent 3 weeks
of DT, pectoral and triceps brachii CSA was still improved
compared to baseline. Trends for changes in strength mirrored
those of npCSA in the main, with significant reductions
in strength at DT1 and DT2 compared to PT. KE MVC
remained greater compared to baseline at DT1, however,
this had diminished by DT2. Previous data has shown that
muscle strength was maintained following 1 month and up
to 3 months of detraining following 3 months of RT (Kubo
et al., 2010). The previous authors suggested this was in
part due to neural adaptations. This may explain in part the
differences observed between the studies. In the current study,
our participants completed 8 weeks of RT using dynamic
muscle contractions and were assed for maximal voluntary
contraction (MVC) via isometric contractions. Kubo et al.
(2010) participants were trained and assessed using isometric
contractions with a 50% longer training duration. Therefore
the neural specificity of adaptations to training and testing
protocol, and longer training time may explain some of the
differences (Folland and Williams, 2007). This is the first study
to report muscle specific force during a period of DT of
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any length. Muscle specific force accounts for many of the
other extrinsic factors present in analyzing the relationship
between muscle size and strength such as angle of fiber
insertion to the aponeurosis, antagonist co-contraction, moment
arm length etc., and requires specific measurements such as
force at optimum fiber length, pCSA, muscle architecture and
muscle volume for example. Specific force has been found to
range between 10 and 40 N.cm−2 in human single muscle
fibers in situ [e.g., Degens et al. (1999)] and between 10 and
100 N.cm−2 in humans in vivo (Narici et al., 1988; Maganaris
et al., 2001). The muscle specific force ranged from 14.2 to
30.5 N.cm−2 in the current study which is also similar to
that previously reported in the VL muscle in vivo in humans
(Maganaris et al., 2001; Reeves et al., 2004b; Erskine et al.,
2010). Muscle specific force did not change during DT, as
mean VL fascicle force declined by −8% from PT to DT2
which was almost identical (−10%) to the observed mean
reduction in npCSA during the same time period. Therefore,
the data from the current study suggests that the intrinsic force
generating capabilities of the muscles do not change following
short term detraining.
Limitations
There are two main limitations in the current study that
are important to highlight. First, the estimation of pCSA is
derived from an estimate of muscle volume using three axial
aCSA measures at 25, 50, and 75% of femur length. The
aCSA estimates are themselves made up of composite axial
ultrasound scans. Therefore there is the potential to over or
underestimate VL muscle volume, and thus pCSA. However,
aCSA measures using the technique outlined in the current
study have been found to be in almost perfect agreement
with MRI measures, with a very small typical error of only
1.7% between the two estimates along the length of the VL
muscle (Reeves et al., 2004a). Furthermore, when multiple
ultrasound axial aCSA scans are combined to estimate VL
muscle volume, there are no significant differences between
the derived muscle volumes of ultrasound and MRI, with a
2.2% mean difference between estimates, which was deemed not
clinically relevant (Walton et al., 1997). Furthermore, Morse
et al. (2007) demonstrated that just a single aCSA axial scan
of the quadriceps at either 40, 50, or 60% of femur length
correlates significantly and highly (R = 0.84, 0.93, and 0.90,
respectively) with the observed quadriceps volume as measured
by MRI. In fact, a single scan at 50 or 60% femur length is
associated with standard error of the estimate (SEE) of only
13 and 10%, respectively. As such, we would argue that taking
three axial scans along the femur length leads to an estimated
VL volume with sufficient accuracy, particularly as the pCSA
calculated that include such error estimates fall comfortably
within the relative changes in pCSA in our results. Lastly, Morse
et al. (2007) reported a mean ± S.D. VL muscle volume of
702 ± 108 cm3 in a group of 18 young recreationally active
men. The mean ± S.D. estimated VL volume at baseline of
the current study’s males within the training group (n = 8)
was 741 ± 102 cm3, and therefore indicates that our current
baseline measure of muscle volume are comparable to that of
a similar homogenous population. The second limitation in the
assessment of muscle architecture with particular reference to
fascicle length, was the use of a 4 cm probe as the entire muscle
fascicle cannot be recorded in one image. Furthermore, due to
the 2D image, the fascicle length may be underestimated when
the digitized fascicles do not lie in the image plane. Therefore,
future studies investigating this may employ a probe with a
scanning width of 6 or 10 cm, or even dual probe approach
due to the relative length of VL fascicles (Brennan et al., 2017;
Franchi et al., 2018). Finally, a further limitation was the use
of a notch filter in the EMG recording system, to remove
mains hum, which would have removed the physiological signal
at this frequency.
CONCLUSION
Following a prolonged period of RT in young healthy individuals,
muscle mass and strength were increased although there were
no effects on the specific force of muscle or on systemic
levels of TNFα. Furthermore, following a period of short-
term detraining, muscle mass and strength were significantly
reduced with muscle mass remaining significantly above
baseline values following the conclusion of the detraining
period. Changes in TNFα were significantly correlated
with the reductions in muscle mass following detraining
compared to post-training. TNFα may play a part in the
detraining induced loss of muscle mass following a period
of RT. However, further work is needed to corroborate
this and the mechanisms by which this may occur are
currently unknown.
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